Interaction of Probenecid with the Breast Cancer Resistance Protein Transporter (BCRP/ABCG2)

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 4, 2006-05 ,pp. : 236-241

Bentham Science Publishers

Access to resources Recommend Favorite

Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor

By Yeboah D.   Sun M.   Kingdom J.   Baczyk D.   Lye S.J.   Matthews S.G.   Gibb W.  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1251-1258

NRC Research Press

Access to resources Recommend Favorite

Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity

By Gunness Patrina   Aleksa Katarina   Koren Gideon  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 9, 2011-07 ,pp. : 675-680

NRC Research Press

Access to resources Recommend Favorite

Lack of Improvement of Oral Absorption of ME3277 by Prodrug Formation Is Ascribed to the Intestinal Efflux Mediated by Breast Cancer Resistant Protein (BCRP/ABCG2)

By Kondo Chihiro   Onuki Reiko   Kusuhara Hiroyuki   Suzuki Hiroshi   Suzuki Michiko   Okudaira Noriko   Kojima Maho   Ishiwata Kazuya   Jonker Johan W.   Sugiyama Yuichi  

Pharmaceutical Research, Vol. 22, Iss. 4, 2005-04 ,pp. : 613-618

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 40-53

Bentham Science Publishers

Access to resources Recommend Favorite